On July 31, Core Scientific, Inc. rose 5.3% in pre-market trading, trading at approximately $22.97 per share, with turnover of $1.46 million.

The move extends bullish momentum after Keefe, Bruyette & Woods upgraded Core Scientific from Market Perform to Outperform in the prior session, raising its price target from $25 to $28. This analyst action, combined with the company's recently announced strategic partnership with AMD for up to 2.5 gigawatts of data center capacity, continues to fuel buying interest. Under the deal, AMD will receive market-priced warrants to purchase Core Scientific shares, with initial capacity exceeding 500 megawatts beginning in 2027 and potential to scale to 2.5 gigawatts.

FactSet consensus data shows the stock carries an average rating of Buy with a mean price target of $36, implying significant upside from current levels and reinforcing pre-market demand. The upgrade reverses a prior downgrade issued just days earlier when the company reported Q2 EPS of negative $3.32, far exceeding expected losses, though quarterly revenue of $164.2 million beat estimates.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)